Table 2.
Bivariate results: unadjusted association of 90-day readmission and state policy
| State Policy | % Readmitted Within 90 Days | 95% CI |
|---|---|---|
| Naloxone standing orders | ||
| Yes | 3.2* | 3.1–3.2 |
| No | 2.8 | 2.8–2.9 |
| Good Samaritan laws | ||
| Yes | 3.2* | 3.2–3.3 |
| No | 1.7 | 1.6–1.8 |
| Methadone coverage by Medicaid | ||
| Yes | 3.0* | 3.0–3.1 |
| No | 1.8 | 1.6–1.9 |
| MAT coverage generosity by Medicaida | ||
| More generous | 3.5* | 3.5–3.6 |
| Less generous | 2.0 | 1.9–2.1 |
CI confidence interval, MAT, medication-assisted treatment
*p < 0.001
aThis is a composite variable of preauthorization requirements for buprenorphine/naloxone, preauthorization for naltrexone, dosing limits for buprenorphine/naltrexone, and substance use disorder counseling requirements